ICON experts frequently author or contribute to industry trade press. The following are some recent articles.
Precision Medicine and Data Science
The future of drug development and the central role that precision medicine will play in global healthcare.
Real-world Evidence and the ‘Unsticking’ of Health Care Data
How Pharma and CROs must set high standards for acceptable real-world evidence research.
The Future of Clinical Trials
In this article Jennifer Byrne discusses the future of clinical trials.
Preparing for 2026
Value-based healthcare, enabled by wearable and electronic health record (EHR) technologies.
2016 FDA Guidance Documents You Should Know
Gordon MacFarlane, senior manager of regulatory affairs and Cynthia Nolte, director of regulatory affairs outline the key points, benefits, and challenges of the FDA guidance documents during 2016 for medical device manufacturers.
One Answer to Your Postmarket Challenge: Planning
Interview with Vicki Anastasi on postmarket surveillance and the challenges trial designs are facing.
The Clinical Trial of the Future
Steve Cutler talks to Pharma Times regarding industry trends in clinical trials and patient engagement.
Due to considerable market growth, biosimilar clinical trials are rising in popularity.
Remote Monitoring of Patients in Clinical Trials
Recent initiatives to redesign the clinical trial process have in part focused on the creation of trials that are more patient focused.
Why Sites Matter
PMG Research contributes to this article on investigative sites and the drug development process.